A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

608

Participants

Timeline

Start Date

December 20, 2010

Primary Completion Date

July 11, 2013

Study Completion Date

July 11, 2013

Conditions
Crohn's Disease
Interventions
DRUG

GSK1605786A

500 mg twice daily, administered orally for 12 weeks

DRUG

GSK1605786A

500 mg once daily, administered orally for 12 weeks

DRUG

Placebo

Placebo capsules, administered orally for 12 weeks

Trial Locations (219)

1000

GSK Investigational Site, Brussels

1050

GSK Investigational Site, Vienna

1088

GSK Investigational Site, Budapest

1090

GSK Investigational Site, Vienna

1148

GSK Investigational Site, Auckland

1200

GSK Investigational Site, Brussels

1640

GSK Investigational Site, Otahuhu

2192

GSK Investigational Site, Parktown

2200

GSK Investigational Site, Bankstown

2650

GSK Investigational Site, Edegem

GSK Investigational Site, Hvidovre

2730

GSK Investigational Site, Herlev

2820

GSK Investigational Site, Bonheiden

3000

GSK Investigational Site, Leuven

3065

GSK Investigational Site, Fitzroy

3116

GSK Investigational Site, Tønsberg

3143

GSK Investigational Site, Tauranga

3181

GSK Investigational Site, Prahran

3204

GSK Investigational Site, Hamilton

4029

GSK Investigational Site, Hersten

5000

GSK Investigational Site, Adelaide

GSK Investigational Site, Odense

5037

GSK Investigational Site, Kurralta Park

5600

GSK Investigational Site, Békéscsaba

6007

GSK Investigational Site, Lower Hutt

6017

GSK Investigational Site, Ålesund

6060

GSK Investigational Site, Hall in Tirol

6160

GSK Investigational Site, Fremantle

7030

GSK Investigational Site, Trondheim

7100

GSK Investigational Site, Szekszárd

7530

GSK Investigational Site, Bellville

7708

GSK Investigational Site, Claremont

7925

GSK Investigational Site, Observatory

8000

GSK Investigational Site, Aarhus

8005

GSK Investigational Site, Bodø

8500

GSK Investigational Site, Kortrijk

8800

GSK Investigational Site, Roeselare

9000

GSK Investigational Site, Ghent

GSK Investigational Site, Aalborg

9038

GSK Investigational Site, Tromsø

9054

GSK Investigational Site, Dunedin

10117

GSK Investigational Site, Berlin

11021

GSK Investigational Site, Great Neck

12157

GSK Investigational Site, Berlin

13353

GSK Investigational Site, Berlin

16132

GSK Investigational Site, Genova

17004

GSK Investigational Site, Prague

20148

GSK Investigational Site, Hamburg

20815

GSK Investigational Site, Chevy Chase

21204

GSK Investigational Site, Towson

22559

GSK Investigational Site, Hamburg

27599

GSK Investigational Site, Chapel Hill

27612

GSK Investigational Site, Raleigh

27710

GSK Investigational Site, Durham

28046

GSK Investigational Site, Madrid

28816

GSK Investigational Site, Brinkum/Stuhr

30625

GSK Investigational Site, Hanover

31096

GSK Investigational Site, Haifa

32127

GSK Investigational Site, Port Orange

32207

GSK Investigational Site, Jacksonville

32423

GSK Investigational Site, Minden

32751

GSK Investigational Site, Maitland

33604

GSK Investigational Site, Pessac

38126

GSK Investigational Site, Braunschweig

38138

GSK Investigational Site, Germantown

38801

GSK Investigational Site, Tupelo

39202

GSK Investigational Site, Jackson

41100

GSK Investigational Site, Modena

42270

GSK Investigational Site, Saint-Priest-en-Jarez

43215

GSK Investigational Site, Columbus

44093

GSK Investigational Site, Nantes

44281

GSK Investigational Site, Kfar Saba

46237

GSK Investigational Site, Indianapolis

48047

GSK Investigational Site, Chesterfield

48098

GSK Investigational Site, Troy

48149

GSK Investigational Site, Münster

48159

GSK Investigational Site, Münster

48960

GSK Investigational Site, Galdakao/Vizcaya

49100

GSK Investigational Site, Petah Tikva

50937

GSK Investigational Site, Cologne

54511

GSK Investigational Site, Vandœuvre-lès-Nancy

55905

GSK Investigational Site, Rochester

58100

GSK Investigational Site, Holon

59037

GSK Investigational Site, Lille

60453

GSK Investigational Site, Oak Lawn

60590

GSK Investigational Site, Frankfurt am Main

60637

GSK Investigational Site, Chicago

64064

GSK Investigational Site, Lee's Summit

64239

GSK Investigational Site, Tel Aviv

67067

GSK Investigational Site, Ludwigshafen am Rhein

70384

GSK Investigational Site, Ostrava - Vitkovice

70403

GSK Investigational Site, Hammond

71201

GSK Investigational Site, Monroe

72205

GSK Investigational Site, Little Rock

74135

GSK Investigational Site, Tulsa

75475

GSK Investigational Site, Paris

77505

GSK Investigational Site, Pasadena

77520

GSK Investigational Site, Olomouc

78229

GSK Investigational Site, San Antonio

78745

GSK Investigational Site, Austin

79106

GSK Investigational Site, Freiburg im Breisgau

80054

GSK Investigational Site, Amiens

80120

GSK Investigational Site, Littleton

80215

GSK Investigational Site, Lakewood

85712

GSK Investigational Site, Tucson

89081

GSK Investigational Site, Ulm

90015

GSK Investigational Site, Los Angeles

90127

GSK Investigational Site, Palermo

91031

GSK Investigational Site, Jerusalem

91120

GSK Investigational Site, Jerusalem

92103

GSK Investigational Site, San Diego

92118

GSK Investigational Site, Clichy

92801

GSK Investigational Site, Anaheim

94115

GSK Investigational Site, San Francisco

97225

GSK Investigational Site, Portland

98101

GSK Investigational Site, Seattle

98195

GSK Investigational Site, Seattle

220701

GSK Investigational Site, Wŏnju

06518

GSK Investigational Site, Hamden

32256-6004

GSK Investigational Site, Jacksonville

30342-5006

GSK Investigational Site, Atlanta

40536-0298

GSK Investigational Site, Lexington

02114

GSK Investigational Site, Boston

48109-5048

GSK Investigational Site, Ann Arbor

03756

GSK Investigational Site, Lebanon

08234

GSK Investigational Site, Egg Harbor City

08043

GSK Investigational Site, Voorhees Township

37212-1610

GSK Investigational Site, Nashville

77034-0550

GSK Investigational Site, Houston

A-4021

GSK Investigational Site, Linz

T2N 4Z6

GSK Investigational Site, Calgary

T6G 2X8

GSK Investigational Site, Edmonton

V2S 3N5

GSK Investigational Site, Abbotsford

V6Z 2K5

GSK Investigational Site, Vancouver

V8V 3M9

GSK Investigational Site, Victoria

R3A 1R9

GSK Investigational Site, Winnipeg

B3H 2Y9

GSK Investigational Site, Halifax

L8N 4A6

GSK Investigational Site, Hamilton

L8S 4K1

GSK Investigational Site, Hamilton

K7L 5G2

GSK Investigational Site, Kingston

N6A 5A5

GSK Investigational Site, London

N6A 5W9

GSK Investigational Site, London

K1H 1A2

GSK Investigational Site, Ottawa

L4B 3P8

GSK Investigational Site, Richmond Hill

M5G 1X5

GSK Investigational Site, Toronto

G6V 3Z1

GSK Investigational Site, Lévis

H3A 1A1

GSK Investigational Site, Montreal

H3T 1E2

GSK Investigational Site, Montreal

G1S 4L8

GSK Investigational Site, Québec

G3K 2P8

GSK Investigational Site, Québec

625 00

GSK Investigational Site, Brno

500 12

GSK Investigational Site, Hradec Králové

100 34

GSK Investigational Site, Prague

140 21

GSK Investigational Site, Prague

190 61

GSK Investigational Site, Prague

06202

GSK Investigational Site, Nice

06847

GSK Investigational Site, Dessau

06120

GSK Investigational Site, Halle

07747

GSK Investigational Site, Jena

00152

GSK Investigational Site, Roma

00168

GSK Investigational Site, Roma

460-0012

GSK Investigational Site, Aichi

466-8560

GSK Investigational Site, Aichi

285-8741

GSK Investigational Site, Chiba

812-8582

GSK Investigational Site, Fukuoka

818-8502

GSK Investigational Site, Fukuoka

060-0033

GSK Investigational Site, Hokkaido

663-8501

GSK Investigational Site, Hyōgo

892-0846

GSK Investigational Site, Kagoshima

892-8512

GSK Investigational Site, Kagoshima

981-3213

GSK Investigational Site, Miyagi

530-0011

GSK Investigational Site, Osaka

545-8586

GSK Investigational Site, Osaka

113-8519

GSK Investigational Site, Tokyo

160-8582

GSK Investigational Site, Tokyo

169-0073

GSK Investigational Site, Tokyo

1315 RA

GSK Investigational Site, Almere Stad

1091 AC

GSK Investigational Site, Amsterdam

1105 AZ

GSK Investigational Site, Amsterdam

6716 RP

GSK Investigational Site, Ede

6419 PC

GSK Investigational Site, Heerlen

3015 CE

GSK Investigational Site, Rotterdam

N-0456

GSK Investigational Site, Oslo

85-168

GSK Investigational Site, Bydgoszcz

85-681

GSK Investigational Site, Bydgoszcz

82-300

GSK Investigational Site, Elblag

20-607

GSK Investigational Site, Lublin

81-756

GSK Investigational Site, Sopot

87-100

GSK Investigational Site, Torun

53-333

GSK Investigational Site, Wroclaw

831 04

GSK Investigational Site, Bratislava

851 01

GSK Investigational Site, Bratislava

851 07

GSK Investigational Site, Bratislava

949 01

GSK Investigational Site, Nitra

915 01

GSK Investigational Site, Nové Mesto nad Váhom

080 01

GSK Investigational Site, Prešov

917 02

GSK Investigational Site, Trnava

705-717

GSK Investigational Site, Daegu

602-739

GSK Investigational Site, Pusan

120-752

GSK Investigational Site, Seoul

130-702

GSK Investigational Site, Seoul

135-230

GSK Investigational Site, Seoul

08916

GSK Investigational Site, Badalona

03293

GSK Investigational Site, Elche

08208

GSK Investigational Site, Sabadell (Barcelona)

SE-416 85

GSK Investigational Site, Gothenburg

SE-221 85

GSK Investigational Site, Lund

SE-171 76

GSK Investigational Site, Stockholm

SE-182 88

GSK Investigational Site, Stockholm

SE-901 85

GSK Investigational Site, Umeå

HA1 3UJ

GSK Investigational Site, Harrow

B9 5SS

GSK Investigational Site, Birmingham

BS2 8HW

GSK Investigational Site, Bristol

EH4 2XU

GSK Investigational Site, Edinburgh

M13 9WL

GSK Investigational Site, Manchester

NE1 4LP

GSK Investigational Site, Newcastle upon Tyne

NG7 2UH

GSK Investigational Site, Nottingham

OX3 9DU

GSK Investigational Site, Oxford

M6 8HD

GSK Investigational Site, Salford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01277666 - A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease | Biotech Hunter | Biotech Hunter